Minimal Clinically Important Difference in Parkinson's Disease as Assessed in Pivotal Trials of Pramipexole Extended Release

Background. The minimal clinically important difference (MCID) is the smallest change in an outcome measure that is meaningful for patients. Objectives. To calculate the MCID for Unified Parkinson's Disease Rating Scale (UPDRS) scores in early Parkinson's disease (EPD) and for UPDRS scores...

Descripción completa

Detalles Bibliográficos
Autores principales: Hauser, Robert A., Gordon, Mark Forrest, Mizuno, Yoshikuni, Poewe, Werner, Barone, Paolo, Schapira, Anthony H., Rascol, Olivier, Debieuvre, Catherine, Fräßdorf, Mandy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995302/
https://www.ncbi.nlm.nih.gov/pubmed/24800101
http://dx.doi.org/10.1155/2014/467131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995302/
https://www.ncbi.nlm.nih.gov/pubmed/24800101
http://dx.doi.org/10.1155/2014/467131

Ejemplares similares